Results 111 to 120 of about 2,541 (178)

Cost-effectiveness of sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer in China. [PDF]

PLoS One
Kang S, Yang S, Jia Y, Zhao S.
europepmc   +1 more source

Individualized Treatment Rules Based on Cost-Effectiveness Criteria in Microsimulations. [PDF]

Pharmacoeconomics
Meier N, Quiroga Gutierrez AC, Pletscher M, Schwenkglenks M.   +3 more
europepmc   +1 more source

The Consistency and Transferability of Economic Evaluations of Disease-Modifying Treatments for Multiple Sclerosis: Analysis of Cost-Effectiveness Assessments from Australia, England, Canada and Scotland. [PDF]

Pharmacoecon Open
Wang X, Zhao F, Newby D, Gao L, Li S.
europepmc   +1 more source

The impact of patent activity on idiosyncratic volatility in U.S. pharmaceutical companies. [PDF]

PLoS One
Atilgan E, Türkmen Ceylan FB, Doruk ÖT, Ertuğrul HM, Barak AY.   +4 more
europepmc   +1 more source

Mapping the Scientific Landscape Between Respiratory Conditions and Costs: A Bibliometric Analysis. [PDF]

Healthcare (Basel)
Lampropoulos IC, Malli F, Aggelopoulos E, Tsameti A, Rouka E, Daniil Z, Gourgoulianis KI.   +6 more
europepmc   +1 more source

A Systematic Review and Quality Assessment of Pharmacoeconomic Publications for China Compared to Internationally: Is the Quality of Evidence-Base Sufficient for Health Technology Assessment? [PDF]

Int J Health Policy Manag
Fan Z, Si X, Wang Z, Zhang L, Liu J, He Q, Franklin M, Sun Q, Yin J.   +8 more
europepmc   +1 more source

Impact of Delisting Non-Prescription Medicines from Health Insurance Coverage on Physicians' Prescribing Behaviour in Iran: A Qualitative Study. [PDF]

J Res Pharm Pract
Raeis Zadeh MM, Borhani M, Soleymani F, Yazdizadeh B, Nikfar S.   +4 more
europepmc   +1 more source

A Method for Comparing Health Inequality Impact Magnitudes, with an Illustration for Hypothetical Treatments of 1336 Diseases. [PDF]

Pharmacoeconomics
Cookson R, Kaur G, Skarda I, Venkatesh S, Doran T, Norheim OF, Paulden M, O'Donnell O.   +7 more
europepmc   +1 more source

Value assessment for health services and procedures: a call to action in a new political climate. [PDF]

J Comp Eff Res
Li M, Neumann P.
europepmc   +1 more source

Developing a value assessment index system of anti-tumour commercial Chinese polyherbal preparation in China: a modified Delphi study. [PDF]

Front Pharmacol
Xia T, Hu M, Luo C, Yang M, Chu M, Xiang X, Zhang Z.   +6 more
europepmc   +1 more source